Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion type Assertion NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_head.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion description "[Among the patients, those who were homozygous for the CYP3A4 variant were more likely to present with clinically more advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_provenance.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion evidence source_evidence_literature NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_provenance.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion SIO_000772 10548319 NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_provenance.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion wasDerivedFrom befree-2016 NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_provenance.
- NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_assertion wasGeneratedBy ECO_0000203 NP266874.RAeg23K75R4XtO941TxickS9g7_afro1ser4mjVnbhpcc130_provenance.